Clinical Trial

VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery

Study acronym: VR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Patients undergoing arterio-venous fistula commonly experience pain and anxiety due to their pre-operative circumstances and the fact that they remain conscious throughout the surgery. It is well documented that perioperative pain and anxiety can cause detrimental effects on patient outcomes and satisfaction. Virtual reality (VR) is increasingly being investigated as an adjunctive tool in various medical and surgical specialties. Current Evidence suggests that VR can be effective in managing both acute and chronic pain, as well as reducing pain, anxiety, stress, and the need for anesthetic agents during surgery. We hypothesize that using VR during AVF surgery will lead to a reduction in anesthetic doses, decreased patient anxiety and pain, and be favorably received by both surgeons and anesthetists.
Trial Details
NCT Number NCT07538687
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Collaborators: McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions End Stage Renal Disease on Dialysis
Enrollment 64 participants
Start Date 2026-06-01
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-20